CVS Health Corporation (CVS BE) stock market data APIs
€62.6452
-0.24(-0.4%)
as of September 17, 2025
Try our APIs with
free plan!
CVS Health Corporation Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for CVS.BE.
Prev. Close
62.6452
Open
62.4079
High
63.6665
Low
62.4079
52 wk Range
40.5364-64.28
Market Cap
115 554 M
Dividends (Yield)
0.0277
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get CVS Health Corporation data using free add-ons & libraries
Get CVS Health Corporation Fundamental Data
CVS Health Corporation Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
CVS Health Corporation News
New
CVS Health declares quarterly dividend
WOONSOCKET, R.I., Sept. 17, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per...
Job seekers feel awful about the labor market. Data is finally starting to explain why.
Since being laid off from her human resources job in the hospitality industry in May, Sashi Cayard has tried it all: walking into businesses to hand over her resume in person, applying to a slew of po...
CVS vs. EVH: Which Value-Based Care Stock Deserves Investor Attention?
The U.S. value-based care (VBC) service market is evolving rapidly, attracting investors for the prospect of long-term stability and compelling returns. Unlike traditional fee-for-service care, the VB...
Novo Nordisk Stock Is a Better Obesity Play Than Eli Lilly, Berenberg Says
Amid a flurry of news out of the world’s leading weight-loss drugmakers Novo Nordisk and Eli Lilly this week, Berenberg broke with the common Wall Street view that Lilly is the better obesity play. ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
